Regeneron Pharmaceuticals, Inc.

Lansforsakringar Fondforvaltning AB (publ) REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

38,088

Value ($000)

29,399

Weight

0.1%

2024 Q4 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	29,399	0.1%	38,088	12/31/2025
2025 Q3	11/10/2025	21,549	0.1%	38,325	9/30/2025
2025 Q2	8/13/2025	19,404	0.1%	36,960	6/30/2025
2025 Q1	5/14/2025	25,294	0.2%	39,882	3/31/2025
2024 Q4	3/14/2025	29,656	0.4%	41,633	12/31/2024